Table: begin end state 1 19 cytoplasmic 20 71 transmembrane 72 108 cytoplasmic 109 139 transmembrane 140 141 non-cytoplasmic 142 144 cytoplasmic 145 184 transmembrane 185 196 non-cytoplasmic 197 223 transmembrane 224 253 cytoplasmic 254 279 transmembrane 280 316 non-cytoplasmic 317 342 transmembrane 343 353 cytoplasmic 354 380 transmembrane 381 387 non-cytoplasmic 388 406 transmembrane 407 412 cytoplasmic 413 440 transmembrane 441 467 non-cytoplasmic 468 489 transmembrane 490 499 cytoplasmic
Input: >AZOBR_RS25235 FitnessBrowser__azobra:AZOBR_RS25235 MDSLGGIAHGLSIAASPANLLYCFAGALLGTFVGVLPGVGPLLTIALLLPFTFSLEPTGA LIMLAGIYYGAQYGGSTTSILLNMPGETSSVVTCIDGHAMARQGRGGPALAVAAIGSFIA GTLSTGIVAFFAPVLAGVAIRFGPADYFSLMVLGLVGAIVLAQGSFVKALAMIVLGLLFG LVGTDVNSGEQRLTFGIQALADGIGFVPVALGVFGIGEIIRILIGQERDGGQVIPHGSLM PSRQDLRDSSGAIARGSVIGSALGLLPGGGAALAAFASYTVEKKLARDPSRFGRGAIEGV AGPESANNAAAQTSFIPLLTLGLPSNAVMALMIGALMLHGITPGPRIMQAEPDLFWGVVA SMWIGNAMLIVLNLPLVGLWVRLLRVPYRFLYPTIVLVSCVGVYGVSNSAFDLVTTAVFG LLGWVLQALRFEPAPLLLGFVLGPMMEENLRRAMILSRGDPTVFLREPISLALLVLTGVL LAAIILPTVRRSRERVFAE
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server